324 related articles for article (PubMed ID: 25550567)
1. Single hepatocellular carcinoma smaller than 2 cm: are ethanol injection and radiofrequency ablation equally effective?
Pompili M; De Matthaeis N; Saviano A; De Sio I; Francica G; Brunello F; Cantamessa A; Giorgio A; Scognamiglio U; Fornari F; Giangregorio F; Piscaglia F; Gualandi S; Caturelli E; Roselli P; Riccardi L; Rapaccini GL
Anticancer Res; 2015 Jan; 35(1):325-32. PubMed ID: 25550567
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial.
Zhang YJ; Liang HH; Chen MS; Guo RP; Li JQ; Zheng Y; Zhang YQ; Lau WY
Radiology; 2007 Aug; 244(2):599-607. PubMed ID: 17641378
[TBL] [Abstract][Full Text] [Related]
3. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma ≤ 4 cm treated with radiofrequency ablation with or without percutaneous ethanol injection.
Shi F; Tan Z; An H; Wang X; Xu Y; Wang S
Ann Hepatol; 2016; 15(1):61-70. PubMed ID: 26626642
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
[TBL] [Abstract][Full Text] [Related]
6. Survival advantage of radiofrequency ablation for hepatocellular carcinoma: comparison with ethanol injection.
Oeda S; Mizuta T; Isoda H; Kuwashiro T; Iwane S; Takahashi H; Kawaguchi Y; Eguchi Y; Ozaki I; Tanaka K; Fujimoto K
Hepatogastroenterology; 2013 Sep; 60(126):1399-404. PubMed ID: 23635508
[TBL] [Abstract][Full Text] [Related]
7. Recurrence incidence of small HCC in cirrhosis patients by ablation versus injection.
Wakui N; Iida K; Ikehara T; Takayama R; Shiozawa K; Takahashi M; Nagai H; Watanabe M; Ishii K; Igarashi Y; Sumino Y
Hepatogastroenterology; 2010; 57(98):195-201. PubMed ID: 20583411
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study.
Ikeda M; Okada S; Ueno H; Okusaka T; Kuriyama H
Jpn J Clin Oncol; 2001 Jul; 31(7):322-6. PubMed ID: 11518745
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm.
Shen A; Zhang H; Tang C; Chen Y; Wang Y; Zhang C; Wu Z
J Gastroenterol Hepatol; 2013 May; 28(5):793-800. PubMed ID: 23432154
[TBL] [Abstract][Full Text] [Related]
10. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations.
Wong SN; Lin CJ; Lin CC; Chen WT; Cua IH; Lin SM
AJR Am J Roentgenol; 2008 Mar; 190(3):W187-95. PubMed ID: 18287411
[TBL] [Abstract][Full Text] [Related]
11. Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1-5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study.
Chen S; Peng Z; Lin M; Chen Z; Hu W; Xie X; Liu L; Qian G; Peng B; Li B; Kuang M
Eur Radiol; 2018 Sep; 28(9):3651-3660. PubMed ID: 29600474
[TBL] [Abstract][Full Text] [Related]
12. Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.
Takayasu K; Arii S; Sakamoto M; Matsuyama Y; Kudo M; Kaneko S; Nakashima O; Kadoya M; Izumi N; Takayama T; Ku Y; Kumada T; Kubo S; Kokudo T; Hagiwara Y; Kokudo N;
Liver Int; 2018 Mar; 38(3):484-493. PubMed ID: 29266722
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat.
Kurokohchi K; Watanabe S; Masaki T; Hosomi N; Funaki T; Arima K; Yoshida S; Nakai S; Murota M; Miyauchi Y; Kuriyama S
Int J Oncol; 2002 Sep; 21(3):611-5. PubMed ID: 12168107
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T
Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
[TBL] [Abstract][Full Text] [Related]
15. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less.
Lin SM; Lin CJ; Lin CC; Hsu CW; Chen YC
Gut; 2005 Aug; 54(8):1151-6. PubMed ID: 16009687
[TBL] [Abstract][Full Text] [Related]
16. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey.
Pompili M; Saviano A; de Matthaeis N; Cucchetti A; Ardito F; Federico B; Brunello F; Pinna AD; Giorgio A; Giulini SM; De Sio I; Torzilli G; Fornari F; Capussotti L; Guglielmi A; Piscaglia F; Aldrighetti L; Caturelli E; Calise F; Nuzzo G; Rapaccini GL; Giuliante F
J Hepatol; 2013 Jul; 59(1):89-97. PubMed ID: 23523578
[TBL] [Abstract][Full Text] [Related]
17. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
[TBL] [Abstract][Full Text] [Related]
19. [Radiofrequency ablation and percutaneous ethanol injection in patients with unresectable hepatocellular carcinoma--a comparative study using Japan Integrated Staging Score (JIS score) system].
Morimoto M; Numata K; Sugimori K; Shirato K; Kokawa A; Oka H; Hirao M; Hirasawa K; Ko R; Saitou T; Imada T; Tanaka K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1592-5. PubMed ID: 16315880
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.
Germani G; Pleguezuelo M; Gurusamy K; Meyer T; Isgrò G; Burroughs AK
J Hepatol; 2010 Mar; 52(3):380-8. PubMed ID: 20149473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
